{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T15:39:19Z","timestamp":1760888359477,"version":"3.37.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.taap.2009.07.029","type":"journal-article","created":{"date-parts":[[2009,7,31]],"date-time":"2009-07-31T16:22:58Z","timestamp":1249057378000},"page":"166-173","source":"Crossref","is-referenced-by-count":22,"title":["Galantamine is a novel post-exposure therapeutic against lethal VX challenge"],"prefix":"10.1016","volume":"240","author":[{"given":"Corey J.","family":"Hilmas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa J.","family":"Poole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"Finneran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew G.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick T.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2009.07.029_bib1","doi-asserted-by":"crossref","first-page":"13220","DOI":"10.1073\/pnas.0605370103","article-title":"Effective countermeasure against poisoning by organophosphorus insecticides and nerve agents","volume":"103","author":"Albuquerque","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.taap.2009.07.029_bib2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0028-3908(03)00317-4","article-title":"Galantamine prevents apoptosis induced by \u03b2-amyloid and thapsigargin: involvement of nicotinic acetylcholine receptors","volume":"46","author":"Arias","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.taap.2009.07.029_bib3","doi-asserted-by":"crossref","first-page":"10646","DOI":"10.1016\/S0021-9258(18)67434-4","article-title":"Kinetic, equilibrium, and spectroscopic studies on dealkylation (\u201caging\u201d) of alkyl organophosphonyl acetylcholinesterase. Electrostatic control of enzyme topography","volume":"261","author":"Berman","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2009.07.029_bib4","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/0006-2952(70)90256-X","article-title":"The use of carbamates and atropine in the protection of animals against poisoning by 1,2,2-trimethylpropylmethylphosphonofluoridate","volume":"19","author":"Berry","year":"1970","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2009.07.029_bib5","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/0272-0590(89)90017-1","article-title":"Interactions of pyridostigmine with cardiopulmonary systems and their relationships to plasma cholinesterase activity","volume":"12","author":"Caldwell","year":"1989","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1016\/j.taap.2009.07.029_bib6","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1152\/physrev.1979.59.4.1105","article-title":"Neurogenesis of respiratory rhythm in the mammal","volume":"59","author":"Cohen","year":"1979","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.taap.2009.07.029_bib7","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1742-1241.2003.tb10467.x","article-title":"Galantamine: a review of its use in Alzheimer's disease and vascular dementia","volume":"57","author":"Corey-Bloom","year":"2003","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.taap.2009.07.029_bib8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/jat.2550140502","article-title":"Review of oximes available for treatment of nerve agent poisoning","volume":"14","author":"Dawson","year":"1994","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.taap.2009.07.029_bib9","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0041-0101(96)00147-X","article-title":"Efficacy of certain quinolines as pharmacological antagonists in botulinum neurotoxin poisoning","volume":"35","author":"Deshpande","year":"1997","journal-title":"Toxicon"},{"key":"10.1016\/j.taap.2009.07.029_bib10","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1176\/ajp.156.10.1500","article-title":"Domestic terrorism with chemical or biological agents: psychiatric aspects","volume":"156","author":"DiGiovanni","year":"1999","journal-title":"Am. J. Psych."},{"key":"10.1016\/j.taap.2009.07.029_bib11","unstructured":"Feaster, S.R., Gordon, R.K., Doctor, B.P., Clark, C.R., Maxwell, D.M., Lenz, D.E., 2000. Unprocessed whole blood cholinesterase levels: WRAIR protocol development and validation. Proc. 2000 US Army Medical Defense Bio Science Rev., 1024\u20131032."},{"key":"10.1016\/j.taap.2009.07.029_bib12","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.2042-7158.1979.tb13503.x","article-title":"The reversal by pyridostigmine of neuromuscular block produced by soman","volume":"31","author":"French","year":"1979","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.taap.2009.07.029_bib13","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0041-008X(78)80045-3","article-title":"The protection of animals against organophosphate poisoning by pretreatment with a carbamate","volume":"43","author":"Gordon","year":"1978","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2009.07.029_bib14","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.2042-7158.1977.tb11246.x","article-title":"Dual mechanism of the antidotal action of atropine-like drugs in poisoning by organophosphorus anticholinesterases","volume":"29","author":"Green","year":"1977","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.taap.2009.07.029_bib15","unstructured":"Hilmas, C.J., Apland, J.P., Deshpande, S.S., Haigh, J., Gordon, R., Adler, M., 2006. Pyridostigmine bromide pretreatment protects against soman-induced lethality in the guinea pig. USAMRICD Technical Report (ICD 06-19)."},{"key":"10.1016\/j.taap.2009.07.029_bib16","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0378-4274(86)90094-9","article-title":"Relationship between the neurotoxicities of Soman, Sarin, and Tabun, and acetylcholinesterase inhibition","volume":"30","author":"Hoskins","year":"1986","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.taap.2009.07.029_bib17","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.bbrc.2004.10.132","article-title":"Galantamine modulates nicotinic receptor and blocks Abeta-enhanced glutamate toxicity","volume":"325","author":"Kihara","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.taap.2009.07.029_bib18","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1527-3458.2002.tb00221.x","article-title":"Galantamine \u2014 a novel cholinergic drug with a unique dual mode of action for the treatment of patients with Alzheimer's disease","volume":"8","author":"Lilienfeld","year":"2002","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.taap.2009.07.029_bib19","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/j.1552-4604.1998.tb04420.x","article-title":"Population pharmacokinetics and pharmacodynamics of pyridostigmine bromide for prophylaxis against nerve agents in humans","volume":"38","author":"Marino","year":"1998","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.taap.2009.07.029_bib20","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0022-3565(25)22225-X","article-title":"Effect of carboxylesterase inhibition on carbamate protection against soman toxicity","volume":"246","author":"Maxwell","year":"1988","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2009.07.029_bib21","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0149-7634(05)80151-4","article-title":"Pharmacological modulation of soman-induced seizures","volume":"17","author":"McDonough","year":"1993","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.taap.2009.07.029_bib22","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0140-6736(95)92170-2","article-title":"Sarin poisoning in Matsumoto, Japan","volume":"346","author":"Morita","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.taap.2009.07.029_bib23","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/00007611-199706000-00002","article-title":"Sarin poisoning on Tokyo subway","volume":"90","author":"Ohbu","year":"1997","journal-title":"South. Med. J."},{"key":"10.1016\/j.taap.2009.07.029_bib24","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/978-3-642-71248-7_58","article-title":"Effects of antidotes on soman-induced brain changes","volume":"9","author":"Pazdernik","year":"1986","journal-title":"Arch. Toxicol., Suppl."},{"key":"10.1016\/j.taap.2009.07.029_bib25","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/neu.10146","article-title":"Unconventional ligands and modulators of nicotinic receptors","volume":"53","author":"Pereira","year":"2002","journal-title":"J. Neurobiol."},{"year":"2008","series-title":"Gulf War Illness and the Health of Gulf War Veterans: Scientific Findings and Recommendations","key":"10.1016\/j.taap.2009.07.029_bib26"},{"key":"10.1016\/j.taap.2009.07.029_bib27","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s002040050670","article-title":"Efficacy of biperiden and atropine as anticonvulsant treatment for organophosphorus nerve agent intoxication","volume":"74","author":"Shih","year":"2000","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.taap.2009.07.029_bib28","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.toxlet.2004.01.022","article-title":"Future applications of phosphotriesterases in the prophylaxis and treatment of organophosporus insecticide and nerve agent poisonings","volume":"151","author":"Sogorb","year":"2004","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.taap.2009.07.029_bib29","series-title":"The Pharmacological Basis of Therapeutics","first-page":"131","article-title":"Anticholinesterase agents","author":"Taylor","year":"1996"},{"key":"10.1016\/j.taap.2009.07.029_bib30","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/0024-3205(90)90429-U","article-title":"Selective inhibition of human acetylcholinesterase by galantamine in vitro and in vivo","volume":"46","author":"Thomsen","year":"1990","journal-title":"Life Sci."},{"key":"10.1016\/j.taap.2009.07.029_bib31","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/BF00316106","article-title":"Stereoselectivity of cholinesterase inhibition by galantamine and tolerance in humans","volume":"39","author":"Thomsen","year":"1990","journal-title":"Eur. J. Clin. Pharm."},{"key":"10.1016\/j.taap.2009.07.029_bib32","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0006-2952(91)90022-W","article-title":"In vitro effects of various cholinesterase inhibitors on acetyl- and butyryl-cholinesterases of healthy volunteers","volume":"41","author":"Thomsen","year":"1991","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2009.07.029_bib33","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1113\/jphysiol.1954.sp005191","article-title":"An analysis of the central and peripheral components of respiratory failure produced by anticholinesterase poisoning in the rabbit","volume":"126","author":"Wright","year":"1954","journal-title":"J. Physiol. (Lond.)"}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X09003160?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X09003160?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T15:57:34Z","timestamp":1739289454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X09003160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0041008X09003160"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2009.07.029","relation":{},"ISSN":["0041-008X"],"issn-type":[{"type":"print","value":"0041-008X"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}